Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.0196
+0.0012 (6.52%)
Nov 2, 2026, 5:23 PM CET
Fidia Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 24.02 | 30.53 | 17.49 | 28.61 | 24.37 | 23.84 |
Other Revenue | -0.54 | 0.03 | 0.05 | 0.13 | 0.3 | 0.34 |
| 23.49 | 30.56 | 17.53 | 28.74 | 24.66 | 24.18 | |
Revenue Growth | 11.14% | 74.30% | -38.98% | 16.52% | 2.01% | 11.65% |
Cost of Revenue | 8.79 | 11.49 | 4.52 | 9.48 | 9.58 | 8.31 |
Gross Profit | 14.69 | 19.07 | 13.02 | 19.26 | 15.09 | 15.87 |
Selling, General & Admin | 9.6 | 9.82 | 10.91 | 11.32 | 10.91 | 10.58 |
Other Operating Expenses | 9.28 | 9.66 | 7.28 | 8.21 | 6.9 | 5.07 |
Operating Expenses | 20.2 | 20.78 | 19.62 | 20.96 | 19.71 | 17.64 |
Operating Income | -5.51 | -1.71 | -6.6 | -1.7 | -4.62 | -1.77 |
Interest Expense | -0.3 | -0.32 | -0.4 | -0.42 | -0.34 | -0.33 |
Interest & Investment Income | 0.02 | 0.02 | 0.07 | 0.07 | 0.02 | 0.02 |
Currency Exchange Gain (Loss) | -0.07 | 0.22 | -0.31 | 0.01 | 0.07 | -0.34 |
Other Non Operating Income (Expenses) | 1.84 | 2.04 | -1.94 | 0.82 | -0.01 | -0.05 |
EBT Excluding Unusual Items | -4.03 | 0.26 | -9.17 | -1.23 | -4.88 | -2.47 |
Gain (Loss) on Sale of Assets | -0.01 | 0.74 | 0.05 | 0.01 | 0.05 | 0.03 |
Asset Writedown | - | - | -0.21 | - | -0.4 | -0.01 |
Other Unusual Items | 0.23 | 0.23 | 0.07 | -0.01 | 10.77 | -1.03 |
Pretax Income | -3.81 | 1.23 | -9.18 | -1.23 | 5.55 | -3.26 |
Income Tax Expense | 0.06 | 0.23 | 0.31 | 0.25 | -0.21 | 0.24 |
Earnings From Continuing Operations | -3.87 | 1.01 | -9.5 | -1.47 | 5.75 | -3.5 |
Minority Interest in Earnings | 0 | 0.03 | 0.2 | 0.17 | 0.21 | 0.29 |
Net Income | -3.86 | 1.04 | -9.3 | -1.31 | 5.97 | -3.2 |
Net Income to Common | -3.86 | 1.04 | -9.3 | -1.31 | 5.97 | -3.2 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 296 | 152 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 296 | 346 | 0 | 0 | 0 | 0 |
Shares Change | 15364.78% | 122259.38% | 308.31% | - | 35.58% | - |
EPS (Basic) | -0.01 | 0.01 | -32.85 | -18.85 | 86.08 | -62.62 |
EPS (Diluted) | -0.01 | 0.00 | -32.85 | -18.90 | 86.08 | -62.62 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.01 | -3.71 | -4.45 | -4.88 | 0.7 | 0.55 |
Free Cash Flow Per Share | -0.02 | -0.01 | -15.71 | -70.41 | 10.08 | 10.84 |
Gross Margin | 62.56% | 62.40% | 74.24% | 67.03% | 61.18% | 65.64% |
Operating Margin | -23.46% | -5.60% | -37.66% | -5.93% | -18.75% | -7.32% |
Profit Margin | -16.44% | 3.40% | -53.03% | -4.55% | 24.20% | -13.24% |
Free Cash Flow Margin | -25.61% | -12.15% | -25.37% | -16.99% | 2.83% | 2.29% |
EBITDA | -5.43 | -1.56 | -6.36 | -1.43 | -4.25 | -1.43 |
EBITDA Margin | -23.13% | -5.12% | -36.27% | -4.97% | -17.22% | -5.91% |
D&A For EBITDA | 0.08 | 0.15 | 0.24 | 0.27 | 0.38 | 0.34 |
EBIT | -5.51 | -1.71 | -6.6 | -1.7 | -4.62 | -1.77 |
EBIT Margin | -23.46% | -5.60% | -37.66% | -5.93% | -18.75% | -7.32% |
Effective Tax Rate | - | 18.33% | - | - | - | - |
Revenue as Reported | 25.39 | 32.4 | 19.06 | 29.94 | 25.85 | 25.28 |